Expanding the CJR Model Is a Logical Step in VBC, but Implementation Challenges Remain

Why It Matters

CJR‑X could standardize value‑based payments for the nation’s most common joint‑replacement surgeries, driving cost containment while improving patient outcomes, but its mandatory nature may strain hospitals lacking the necessary infrastructure.

Key Takeaways

• CJR‑X expands mandatory joint‑replacement bundle to all Medicare hospitals
• Model targets 90‑day episode cost, offering bonuses or penalties
• CMS reports $112.7 million savings from 2021‑2023 pilot
• Smaller hospitals fear infrastructure costs for 90‑day episode management
• Experts debate mandatory rollout versus phased voluntary participation

Pulse Analysis

Joint replacement procedures—hip, knee and ankle—represent a high‑volume, predictable segment of Medicare spending, making them a natural entry point for value‑based care. Since 2016, CMS has piloted the Comprehensive Care for Joint Replacement (CJR) Model in 34 metropolitan areas, bundling surgery, hospital stay and post‑acute care into a single episode. The pilot demonstrated measurable success, delivering $112.7 million in savings while maintaining quality metrics, which has emboldened policymakers to consider a broader, mandatory rollout.

The proposed CJR‑X model extends the episode window to 90 days and mandates participation for most hospitals under the Inpatient Prospective Payment System. By setting a target spending level for the entire episode, CMS aims to align financial incentives with patient outcomes: hospitals that stay below the benchmark receive a bonus, while those that exceed it must repay funds. This risk‑adjusted structure differs from earlier programs like the Hospital Readmissions Reduction Program, which only penalized excess readmissions, and from the 30‑day episode model of the Transforming Episode Accountability Model (TEAM). The longer window captures downstream complications, encouraging deeper care coordination and potentially larger savings.

Implementation, however, poses significant challenges. Smaller and rural hospitals may lack the data analytics, care‑management teams, and post‑acute networks required to monitor and influence 90‑day outcomes, raising concerns about financial strain and possible unintended penalties. Industry leaders such as the American Hospital Association advocate for a phased or voluntary approach to allow providers time to build the necessary infrastructure. Balancing the promise of cost containment with the practical realities of hospital capacity will determine whether CJR‑X can achieve its dual goals of fiscal responsibility and improved patient experience across the Medicare landscape.